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These studies provided an in-depth understanding of the key
process parameters and methods of flavour production used
in the manufacture of enzyme modified cheese (EMC)
products, thereby facilitating the successful production of
these cheese flavour ingredients.
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principally used as an ingredient in processed foods, where they provide a cost-effective
alternative to natural cheese.  They can be used as the sole source of cheese flavour to
intensify an existing cheese taste, or to impart a specific cheese character to a more bland
product.  Their main applications are in processed cheese, analogue cheese, cheese
spreads, snack foods, soups, sauces, biscuits, dips and pet foods.  Their main advantages
over other cheese flavour ingredients are: low production costs, consistency, high flavour
intensity, diverse flavour range, extended shelf- life, low storage costs and increased
functionality.
EMCs are generated utilising the same flavour pathways that occur in natural cheese
ripening i.e. proteolysis, lipolysis and glycolysis.  They are not as easy to differentiate as
natural cheeses, as they are characterised by flavour and aroma alone as texture is not a
factor in EMC production.  The relationship of the flavour of EMCs to the flavour of the
corresponding natural cheese remains unclear.  This is especially true for Cheddar EMC
which is commercially available in a range of Cheddar flavours.  Despite the fact that a
wide range of commercial EMCs are available, there is very little detailed information
available regarding their properties or the specific production processes used.
The main objective of this research was to build a knowledge base on EMC products and
to utilise this to develop a biotechnological process for the production of improved enzyme
modified cheeses for use as flavour ingredients. The strategy was to establish quantitative
relationships between the compositional, proteolytic and lipolytic parameters and the
sensory characteristics of EMCs.  This data would then be used to develop a predictive
model for flavour development in EMC production and the subsequent generation of an
optimised EMC process enabling the generation of a range of cheese flavours from single
or multiple substrates.
Main Conclusions and Achievements
High levels of proteolysis and lipolysis are an integral feature of Cheddar EMC products.
However, most commercial products tested were not perceived as having a Cheddar cheese
flavour profile.  Manipulation of proteolytic, lipolytic and compositional parameters, as well
as the addition of flavour potentiators, organic acids and bulking agents were identified as
being used to produce Cheddar EMC products of different characteristics.
A number of commercial enzyme preparations were identified for their flavour generating
potential in EMC systems.  Commercial proteinase, peptidase and lipase preparations from
microbial and animal sources were found to contain large differences in active enzymes and
protein content.
A laboratory scale EMC system was developed and successfully used to assess the de-
bittering potential of a combination of purified peptidase enzymes (aminopeptidases).
A prototype pilot plant EMC process has been developed and used to generate Cheddar
flavoured EMC products.
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Summary and
Conclusions
Enzyme-modified cheeses (EMCs) are defined as concentrated cheese
flavours produced enzymatically from cheeses of various ages and are
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Database of Cheddar EMC products
Initially, a wide range of EMC flavours were investigated, such as Blue, Swiss, Gouda,
Mozzarella and Parmesan.  However, because of its commercial importance in Ireland it
was decided to focus on Cheddar EMC.  Cheddar EMC was also of interest because it is
available as a range of purported Cheddar flavours and intensities from different
manufactures.
Fifteen commercial Cheddar EMC products were obtained from eight suppliers in paste and
powdered formats.  The compositional parameters analysed were moisture, protein, fat,
NaCl, pH, ash, phosphate and calcium.  Proteolysis was measured by urea-PAGE, the
percentage of total N soluble in water at pH 4.6 (pH 4.6 WSN) and 5% phosphotungstic
acid (PTA-N), the molecular mass distribution of soluble peptides in the pH 4.6 water
soluble extract (pH 4.6 WSE), the free amino acid content (FAA) of the pH 4.6 WSE, and
peptide profiles by Reverse Phase -HPLC of pH 4.6 WSE.
Results shown in Table 1 are the averages of the compositional parameters analysed for
paste Cheddar EMC products and for typical natural Cheddar cheeses.  Table 2 shows the
average proteolytic data from these same products.  The compositional and proteolytic
indices varied widely, with most products having high levels of proteolysis.  It was evident
from these results that manipulation of both compositional and proteolytic parameters is a
feature of Cheddar EMCs. The use of emulsifying salts, flavour potentiators, bulking agents,
cheeses of varying fat and/or the addition of exogenous protein or fat was also indicated in
these commercial products.  This work is presented in full in Kilcawley et al. (2000).
Table 1: Compositional data for commercial Cheddar EMC pastes and typical natural Cheddar cheese
Moisture Protein           Fat NaCl pH
(%) (mg/g*)        (mg/g*) (mg/g*)
n          Av       sd     Av       sd     Av       sd    Av      Sd    Av     sd
Cheddar EMC 13        54.4     7.9    35.1    7.8    52.2   10.9    7.4     4.6     4.8     0.7
Cheddar cheese 4       36.5     1.0    40.6    1.1    54.0    2.3    2.8    0.2     5.0    0.1
* dry wt basis
Table 2: Proteolytic data for commercial Cheddar EMC pastes and typical natural Cheddar cheeses
WSN PTA FAA 
(%) (%) (mg/g*)
n     Mean        sd       Mean       sd Mean       sd
Cheddar EMC                         13    49.7 18.5 26.7 21.9 60.7 40.7
Cheddar cheese                       4 22.2 6.9 5.6 2.8 22.3 13.9
* dry wt basis
WSN = pH 4.6 water soluble nitrogen. PTA = 5% Phosphotungstic acid soluble nitrogen.
FAA = Free amino acid.
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Research and Results
Basis of EMC production
The basis of EMC production is the utilisation of specific enzymes, under optimum
conditions, to produce intense cheese flavours rapidly from dairy substrates (usually cheese
curd).  The technology was developed in the late 1960s where fresh curd and a NaCl
solution were mixed to make an emulsion of approximately 40% solids.  Enzymes and
preservatives were added and the mixture was incubated under controlled conditions, after
which characteristic cheese flavours developed.  This work demonstrated the potential of
generating a range of intense cheese flavours in a short time from cheese substrates by
modification of process parameters.
Many commercial procedures are based on similar principles and in general, production
involves incubating mature or immature cheese with specific exogenous enzymes and/or
micro-organisms, terminating the process by heat treatment, and standardising the final
product to a desired flavour intensity and composition.  EMCs are generally produced
either by a one step process (Fig 1 - Page 10), in which hydrolysis of fat and protein occur
simultaneously, or by a component approach (Fig 2 - Page 11), where several different
flavour components are created separately and then blended together.  The component
approach allows greater flexibility, facilitating greater diversity of products.
The actual processing conditions used depend upon many factors and directly relate to the
enzymes being used.  In general, EMCs are produced between 12 to 72h in a temperature
range of 30 - 45°C, and between  pH of 5 - 7 (Kilcawley et al., 1998).  Once a product has
been produced it may be formulated to a desired composition depending upon its final
application.  The pH may be altered to improve storage stability, or flavour, while bulking
agents or carriers may be added to increase yield, obtain a desired flavour intensity or to
facilitate spray drying.
Experimental Approach
The major objective of this research was to develop a biotechnological process for the
production of EMCs for use as flavour ingredients.
The steps to achieving this objective involved:
- Compilation of a database of the compositional, proteolytic, lipolytic indices and sensory
evaluation of a range of commercial EMC products
- Compilation of a database of the enzyme activities (proteinase, peptidase, lipase and
esterases) present in commercial enzyme preparations used in the manufacture of EMCs 
- Development of a laboratory-scale EMC process to investigate the flavour generating
and/or de-bittering potential of various enzyme combinations
- Development of a prototype pilot biotechnological process for the manufacture of EMC
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API-ZYM test method.  Each preparation was also analysed for specific proteinase activity
at pH 5.5 and pH 7.0 at 37°C using azocasein.  
Proteinases of interest were further evaluated in a sodium caseinate system, monitoring
hydrolysis by urea-PAGE and RP-HPLC and free amino acid analysis and assessed for
specific peptidase, lipase and esterase content at pH 7.0 at 37°C.  Peptidase preparations
were assessed for a number of specific peptidase activities; at both pH 7.0 and pH 5.5 at
37°C (general amino peptidase activity; leucine aminopeptidase, Post-proline dipeptidyl
aminopeptidase; PepX, proline imino-peptidase; PepI, aminopeptidase A; PepA,
aminopeptidase P; PepP, aminopeptidase M; PepM, endoproteinase O; PepO,
carboxypeptidase and endopeptidase activity).
Lipase preparations were assessed for both esterase and lipase activity at pH 7.0 at 37°C.
Brief summary of evaluations
Proteinases
The protein content of the proteinase preparations was found to vary as was their specific
proteinase activities. All preparations were found to contain other contaminating side
activities.  The preparations derived from Aspergillus and Rhizomucor species contained
more peptidase side activities than the preparations derived from Bacillus species.  Only
two products contained lipase activity, but most contained esterase activity.
Bacillus species had higher proteinase activity at pH7.0 and Aspergillus and Rhizomucor
species had higher proteinase activity at pH5.5.
Peptidases
The protein content and proteinase activities of these preparations were also found to vary.
All preparations contained varying amounts of different specific peptidase activities, with
higher activities at pH 7.0 than at pH 5.5. Most preperations contained contaminating
enzyme side activities.
In general those derived from Aspergillus had the highest levels of general
aminopeptidase activity, with those derived from Lactococcus lactis having the highest
levels of PepX activity.
Lipases
The protein content of the lipase preparations was found to vary.  Little or no peptidase
activity was determined in these preparations.  Large differences were determined in the
esterase and lipase activities of each preparation.
Novel purified enzymes
The de-bittering potential of a combination of purified aminopeptidases was evaluated in
a laboratory-scale EMC system.  A curd slurry substrate was inoculated with a high dosage
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The free fatty acid (FFA) and lactic acid contents of these same Cheddar EMC products
were also quantified.  The lactic acid content was determined using a UV test kit method.
Short chain volatile FFA (C2:0, C3:0, C4:0) were extracted by steam distillation and
quantified using ion - partition HPLC,  medium and long chain FFAs (C6:0, C8:0, C10:0,
C12:0, C14:0, C16:0, C18:0, C18:1, C18:2, C18:3) were isolated, esterified and quantified by RP-
HPLC.  
Results for FFA and lactic acid contents of the paste Cheddar EMCs and natural
commercial Cheddar cheeses are summarised in Table 3.  These results confirm that levels
of lipolysis were higher in commercial Cheddar EMCs than in natural Cheddar cheese.
Levels of lipolysis varied widely between individual EMCs indicating that manipulation of
lipolysis is used to generate a range of Cheddar EMC products (in addition to manipulation
of composition and proteolysis).  Addition of exogenous acetic acid, butyric acid and lactic
acid was evident in certain EMCs and indicates their possible uses as flavour potentiators
and/or to reduce pH.  (Kilcawley et al. [In Press]).
Table 3: Levels of different acids in commercial Cheddar EMC pastes and typical natural Cheddar
cheese
Acetic Acid    Propionic Acid    Butyric Acid    Lactic Acid   Total FFA
(mg/g*) (mg/g*) (mg/g*) (mg/g*)     (C6:0-C18:3)*
(mg/g*)
n Av      Sd          Av      Sd         Av      Sd        Av      Sd    Av      Sd
Cheddar EMC 13  36.1   97.1        3.4     5.9       36.0    34.4     50.6   72.5  24.4    9.5
Cheddar cheese 4    0.7     0.4         nd                  0.6      0.1     19.7     2.2    3.5    1.7
*dry wt basis
The sensory characteristics of EMCs were determined by quantitative descriptive analysis
by a trained sensory panel.  Due to the high flavour intensity, the commercial EMCs were
assessed in a bland cheese slurry at 10% (w/w) of its original concentration.  The sensory
profiles of the Cheddar EMCs were found to be significantly different to the sensory
characteristic used to describe natural Cheddar cheese.  Positive correlation was found
between flavour intensity and certain compositional parameters.  This study is described in
detail in Hulin-Bertaud et al. (In Press).
Database on commercial and novel enzymes
Fifty commercially available enzyme preparations were obtained from 10 different enzyme
suppliers.  These preparations consisted of proteinases, peptidases, lipases or mixtures
thereof.  All of the proteinases were derived from microbial sources (Bacillus, Aspergillus or
Rhizomucor spp.), as were the peptidases (Aspergillus, Rhizomucor or Lactococcus lactis).
The lipases were derived from both animal (calf, kid and lamb) and microbial sources
(Aspergillus, Rhizopus, Mucor, Candida or Penicillium spp.).
All enzyme preparations were analysed for protein content, semi-quantitative tests for the
presence of lipase, proteinase, peptidase, phosphatase and carbohydrase activity, using the
Fig 2: EMC Process - Component Approach for the Production of Enzyme Modified Cheeses
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of the commercial proteinase, Neutrase 0.5L (Novo Nordisk A/S) derived from Bacillus
subtilis which had previously been shown to accelerate Cheddar cheese flavour
development, but accumulate bitterness.  Neutrase 0.5L was used in this study to generate
an excessively bitter curd slurry which was then treated with a combination of three purified
peptidases isolated from Lactococcus lactis subsp. cremoris AM2; aminopeptidase KpNA-H
(lysyl-nitranilide hydrolyase), PepX and PepP.  KpNA-H cleaves all amino acids from the N-
terminal of peptides up to the imido bond (the peptide bond preceding the proline residue).
The proline present in the second position was then removed by the action of PepX, which
also enables the general aminopeptidase to continue to hydrolyse the peptide.  However if
the imido bond is followed by consecutive proline residues (e.g. in positions 2 and 3) PepX
cannot remove the Pro-X dipeptide due to the presence of this second proline.  PepP can
however, remove the amino acid preceding proline (position 1) which then enables PepX
to remove the Pro-Pro dipeptide, thus allowing the general aminopeptidase to continue to
hydrolyse the peptide and reduce bitterness.  Addition of these purified peptidases were
shown to significantly reduce bitterness (~ 40%) in the Neutrase-treated cheese slurry. This
work has demonstrated the potential of utilising purified peptidases to alleviate the problem
of bitterness in specific applications, such as in EMC manufacture.
Development of a prototype EMC process
Preliminary work to develop a prototype pilot plant EMC process has utilised the
knowledge gained of commercial Cheddar EMCs, commercial enzymes and the novel
laboratory scale de-bittering process.  Preliminary trials of this process have enabled the
successful production of Cheddar and Blue EMC flavours at laboratory scale and Cheddar
EMC flavour at pilot scale.
Fig 1: EMC Process - One Step Approach for the Production of Enzyme Modified Cheeses 
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